23 Jul, 2026
According to Straits Research the global dermatological therapeutics market was valued at $51.46 billion in 2025 and is anticipated to grow from $56.09 billion in 2026 to $111.81 billion by 2034, registering a CAGR of 9% during the forecast period 2026–2034.Dermatology is the branch of science that deals with skin and its appendages, such as nails, hairs, and sweat glands, among others. Today, the urban population’s primary major remains skincare and skin hygiene. Rising pollution levels have seen an increase in the instances of skin allergies and the prevalence of chronic diseases, such as skin cancer, acne vulgaris, psoriasis, and atopic dermatitis. As per a study by Clinical Dermatology, around 25% of the population across the world suffers from skin disorders, of which 15% consult general practitioners, and 1.2% consult dermatologists. The study also reveals skin problems are the fourth leading cause of the burden of nonfatal diseases. The dermatological therapeutics market is expected to be an exceptionally dynamic and competitive market in the near future.
The ongoing coronavirus pandemic has led to a paradigm shift in living and shopping habits across the world, and the dermatological market has borne a significant share of this shake-up. The global outbreak has led to severe economic consequences within the healthcare and dermatological markets. The pandemic has changed consumer behavior in terms of the use of dermatological products, and consumers now have limited access to advanced dermatological therapies. Moreover, disruptions in the supply chains of key pharmaceutical market players have led to a decrease in their revenue in the dermatological segment.
sales@straitsresearch.com